Introduction {#S0001}
============

Chronic obstructive pulmonary disease (COPD) is a worldwide disease, characterized by persistent airflow limitation that is progressive and associated with an enhanced inflammatory response in airways and lungs \[[@CIT0001]\]. To date, although the underlying mechanisms of COPD remain not fully elucidated, a genetic predisposition of COPD has been strongly evidenced \[[@CIT0002]--[@CIT0004]\].

Interleukin (IL)-1β, a proinflammatory cytokine, is encoded by the IL1B gene on chromosome 2q14, which is identified as a candidate gene of COPD \[[@CIT0005]\]. In the past decade, the relationship of polymorphisms in the IL1B gene with COPD risk has been well studied, including the --31T/C promoter polymorphism in the IL1B gene with the potential to alter the transcriptional activity \[[@CIT0006]\]. However, inconsistent results were reported \[[@CIT0007]--[@CIT0011]\], which may be owing to differences in ethnicity and sample size in individual studies, resulting in lower statistical power. It is suggested that meta-analysis could be a useful means to pool the independent statistical powers and thus achieve a quantitative understanding of the associations. Accordingly, in the present study, a meta-analysis was performed to determine IL-1β --31T/C promoter polymorphism and the risk of COPD.

Material and methods {#S0002}
====================

Search strategy {#S20003}
---------------

The literature search was conducted using PubMed and China National Knowledge Infrastructure (CNKI) (<http://www.cnki.net/>) databases. CNKI database was founded by Tsinghua University of China in 1996 and includes over 8000 Chinese journals covering natural and social sciences. The languages were limited to English and Chinese. The following search terms were utilized: interleukin 1beta or interleukin 1b or IL1beta or IL1b, and polymorphism or variant or SNP or genotype, and chronic obstructive pulmonary disease or COPD.

Data extraction {#S20004}
---------------

Two independent reviewers collected the data according to the inclusion and exclusion criteria. For inclusion in the meta-analysis, retrieved articles had to inform about the number of cases and controls, and the number of individual genotypes in cases and controls. Exclusion criteria in the meta-analysis were 1) not case-control genetic study, 2) duplicated report, 3) no useful data reported, 4) other IL-1β polymorphisms than --31T/C. Unpublished data were not considered. Disagreement was resolved by discussion before reaching a consensus. If more than one article was published by the same group using the same cases, the study with a higher sample size was selected.

Statistical analysis {#S20005}
--------------------

Categorical variables are presented as odds ratio (OR) with 95% confidence interval (CI). CC, TC and TT are the genotypes of IL-1β --31T/C polymorphism. OR1, OR2 and OR3 were calculated as follows: OR1: CC vs. TT; OR2: TC vs. TT; OR3: CC vs. TC. These pairwise differences (OR1, OR2 and OR3) were used to indicate the most appropriate genetic model as follows: if OR1 = OR2 ≠ 1 and OR3 = 1, then a dominant model was suggested; if OR1 = OR3 ≠ 1 and OR2 = 1, then a recessive model was suggested; if OR2 = 1/OR3 ≠ 1 and OR1 = 1, then a complete overdominant model was suggested; if OR1 \> OR2 \> 1 and OR1 \> OR3 \> 1 (or OR1 \< OR2 \< 1 and OR1 \< OR3 \< 1), then a codominant model was suggested. Once the best genetic model was identified, this model was used to collapse the three genotypes into two groups (except a codominant model) and to pool the results again. Pooled ORs with 95% CI were calculated and *p* \< 0.05 was accepted as statistical significance. Heterogeneity was checked by the *Q* test. Meta-analysis was done with the fixed-effects model when there was no heterogeneity (*p* ≥ 0.1). Otherwise, the random-effects model was used. Subgroup analysis was performed by ethnicity to assess the effect of possible clinical heterogeneity on the summary ORs. Pearson\'s χ^2^ test was used to determine whether the observed frequencies of genotypes in controls conformed to the Hardy-Weinberg equilibrium (HWE). Studies with controls that depart from HWE (*p* \< 0.05) were subjected to a sensitivity analysis in order to check the consistency of the overall effect size. Funnel plots, as well as Begg\'s rank correlation test and Egger\'s linear regression test, were used to assess the potential publication bias, and *p* \< 0.05 was considered significant publication bias. All analyses were conducted using Revman 5.0 (Oxford, UK, The Cochrane Collaboration) and Stata 11.0 (StataCorp LP, College Station, TX, USA) \[[@CIT0012]\].

Results {#S0006}
=======

Studies included in the meta-analysis {#S20007}
-------------------------------------

Sixteen studies were relevant to the search terms. After reviewing the titles, abstracts and articles, 11 studies were excluded; thus 5 articles with 6 case-control studies for --31T/C matched the inclusion criteria ([Figure 1](#F0001){ref-type="fig"}). Of the 5 included articles, 4 were published in English, and 1 was published in Chinese. These studies were carried out in China, Japan, Korea, Egypt, and Taiwan. Notably, the study by Hegab *et al*. \[[@CIT0008]\] was performed in two ethnic populations (Japan and Egypt). The main features of the studies included in this meta-analysis are presented in [Table I](#T0001){ref-type="table"}.

![Flow diagram of search process](AMS-10-23009-g001){#F0001}

###### 

Main characteristics of included studies

  Ref.             Country   Race        Genotyping      Source of control    COPD   Control                                      
  ---------------- --------- ----------- --------------- -------------------- ------ --------- ----- ---- ----- ----- ----- ----- --------
  \[[@CIT0004]\]   Japan     Asian       PCR+RFLP        Healthy population   68     20        32    16   85    20    40    25    0.8771
  \[[@CIT0005]\]   Japan     Asian       PCR+RFLP        Healthy population   88     16        52    20   60    8     31    21    0.8082
  \[[@CIT0005]\]   Egypt     Caucasian   PCR+RFLP        Healthy population   105    11        45    49   71    16    29    26    0.3734
  \[[@CIT0006]\]   Korea     Asian       ABI sequencer   Healthy men          311    74        179   58   386   109   177   100   0.2696
  \[[@CIT0007]\]   China     Asian       PCR+RFLP        Healthy population   162    29        101   32   162   27    99    36    0.0159
  \[[@CIT0008]\]   Taiwan    Asian       PCR+RFLP        Healthy population   30     6         18    6    115   23    64    28    0.4665

HWE -- Hardy-Weinberg equilibrium, PCR -- polymerase chain reaction, Ref -- reference, RFLP -- restriction fragment length polymorphism

Quantitative synthesis {#S20008}
----------------------

In order to indicate the most appropriate genetic model, OR1, OR2 and OR3 were calculated. Results showed OR1 = 1.12, OR2 = 1.38 and OR3 = 0.80 for --31T/C, suggesting an overdominant genetic model (CC+TT vs. TC). The pooled effect size showed that there was a significant association of IL-1β --31T/C with the risk of COPD (OR: 0.77, 95% CI: 0.63--0.94, *p* = 0.009, fixed model, [Figure 2](#F0002){ref-type="fig"}). In the subgroup analysis by ethnicity, the results indicated that IL-1β --31T/C was significantly correlated with COPD susceptibility in Asians (OR: 0.75, 95% CI: 0.61--0.93, *p* = 0.008, fixed model, [Figure 3](#F0003){ref-type="fig"}).
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Test of heterogeneity {#S20009}
---------------------

Significant heterogeneity was not revealed between all studies in CC+TT vs. TC comparison (overdominant model) for --31T/C (*I*^2^ = 0%, *p* = 0.59). When stratified by ethnicity, no heterogeneity was observed between the studies in Asians.

Sensitivity analyses {#S20010}
--------------------

In the present meta-analysis, in only one study \[[@CIT0010]\] was there lack of HWE, which had a potential to influence the robustness of the present meta-analysis. After exclusion of this study, the pattern of the pooled effect size persisted, while the overall heterogeneity was not significantly altered for --31T/C (*I*^2^ = 0%, *p* = 0.62), indicating that this study might not contribute to the overall heterogeneity.

Publication bias {#S20011}
----------------

The funnel plots showed no significant asymmetry in this meta-analysis ([Figure 4](#F0004){ref-type="fig"}). Moreover, publication bias was not suggested by Begg\'s rank correlation test (*p* = 1.000) or Egger\'s linear regression test (*p* = 0.138).

![Begg\'s funnel plot for evaluation of publication bias in the included studies on the associations of IL-1β --31T/C with COPD risk](AMS-10-23009-g004){#F0004}

Discussion {#S0012}
==========

IL-1β, a proinflammatory cytokine, contributes to the pathogenesis of COPD. Recently, association of IL-1β --31T/C promoter polymorphism with COPD risk caught more attention, owing to its potential to alter the transcriptional activity.

The pooled effect size showed that IL-1β --31T/C was significantly associated with COPD susceptibility in an overdominant genetic model, indicating that homozygotes (CC and TT) had a decreased risk for COPD compared with heterozygotes (TC). Significant heterogeneity was not revealed between all studies in CC+TT vs. TC comparison for --31T/C. In the subgroup analysis by ethnicity, the results indicated that IL-1β --31T/C was significantly correlated with COPD susceptibility in Asians, further suggesting a protective role of IL-1β --31T/C in COPD pathogenesis in Asians. After exclusion of the study without HWE by Liu *et al*. \[[@CIT0010]\], the pattern of the pooled effect size persisted, while the overall heterogeneity was not significantly altered for --31T/C, indicating that this study might not contribute to the overall heterogeneity. Publication bias was not suggested in the present study, possibly owing to the deliberate search strategy and data extraction.

However, some limitations should be considered in this meta-analysis. First, large sample size studies were lacking and the pooled statistical power might be insufficient. Second, the pooled estimates were not based on adjustment by confounding factors, such as sex, age, and smoking history. Third, the lack of original data in the studies limited our further analysis of the potential interactions between gene and gene, or gene and environment, which might modulate COPD risk.

In conclusion, although the pooled estimates should be interpreted with caution, our meta-analysis suggests that IL-1β --31 T/C promoter polymorphism confers protection against COPD in Asians. However, large sample size studies with unbiased genotyping methods, standardized defined COPD cases and matched controls in different populations, as well as more detailed data about individual and environment, are warranted.
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